In a longitudinal follow-up study including 32 COVID−19 patients and 16 influenza-associated pneumonia patients who had similar clinical characteristics to the COVID-19 patients, SARS-CoV-2, but not influenza virus, could trigger an untuned immune response that presented as suppressed and delayed IFN responses and a persistent inflammatory response (45). Here, IFNA1 is linked to COVID-19.